Health - Google News: Vertex Revises Interim Results Of Cystic-Fibrosis Study; Shares Drop - Wall Street Journal

Health - Google News Google News

Vertex Revises Interim Results Of Cystic-Fibrosis Study; Shares Drop - Wall Street Journal May 29th 2012, 12:10 CNBC.com Vertex Revises Interim Results Of Cystic-Fibrosis Study; Shares Drop Wall Street Journal Vertex Pharmaceutical Inc. (VRTX) revised the interim results of a recent clinical trial of cystic-fibrosis patients that had exceeded expectations and boosted hopes that the drug therapy tested could have blockbuster sales potential. Vertex Revises Cystic Fibrosis Combo DataBloomberg Vertex Corrects, gives Addl. Data From Analysis Of Study Of VX-809 & KALYDECORTT News Vertex Corrects Cystic Fibrosis Data; Shares TumbleCNBC.com TheStreet.com all 22 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: